Status:

COMPLETED

Remotely Delivered Behavioral Weight Loss Using an Ad Libitum Plant-Based Diet Versus a Balanced Calorie Deficit Diet

Lead Sponsor:

Drexel University

Conditions:

Obesity

Overweight

Eligibility:

All Genders

18-75 years

Phase:

NA

Brief Summary

This pilot randomized controlled trial will compare a remotely delivered behavioral weight loss program with a balanced calorie deficit diet (the current gold-standard) to a behavioral weight loss pro...

Eligibility Criteria

Inclusion

  • BMI 27-50 kg/m2
  • Ages 18-75 years
  • Resides in the U.S.
  • Consistent access to internet at home
  • Proficient skill level in speaking, writing, and understanding English
  • Reporting a desire to lose weight
  • Consistently available for 15-minute once-weekly video appointment between the hours of 8 AM and 7 PM EST
  • Willing to follow a whole food plant-based diet or a traditional calorie-reduced diet for the study duration
  • Individuals must provide consent for the research team to contact their personal physician if necessary, to provide clearance or to consult about rapid weight loss

Exclusion

  • Currently pregnant or breastfeeding or planned pregnancy within the study period
  • Recent weight loss (≥ 5% weight loss in 3-months prior to the study)
  • History of bariatric surgery
  • Currently following a low-fat plant-based diet
  • Medical condition (e.g., cancer, type I diabetes, renal failure), current substance use problem, or psychiatric condition (e.g., active substance abuse, eating disorder) that may pose a risk to the participant during intervention or cause a change in weight
  • Recently began or changed the dose of a medication that can cause significant change in weight
  • Planning on quitting cigarette smoking over the program period
  • Participation in a concurrent weight loss program during the study period
  • Medical diagnosis currently influencing weight or appetite
  • Medical condition that would limit ability to participate in this program (for example, mild stroke, diabetes if taking insulin, head trauma, cognitive disorder)
  • Acute suicidality
  • Currently meets criteria for regular loss-of-control eating (i.e., ≥ 9 binge episodes in past 3 months
  • Currently reports engaging in a compensatory behavior

Key Trial Info

Start Date :

May 29 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 24 2023

Estimated Enrollment :

55 Patients enrolled

Trial Details

Trial ID

NCT05337150

Start Date

May 29 2022

End Date

March 24 2023

Last Update

September 14 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Drexel University

Philadelphia, Pennsylvania, United States, 19104